Gadolinium retention: a research roadmap from the 2018 NIH/ACR/RSNA workshop on gadolinium chelates
Gadolinium-based contrast agents (GBCAs) have revolutionized MRI, enabling physicians
to obtain crucial life-saving medical information that often cannot be obtained with other …
to obtain crucial life-saving medical information that often cannot be obtained with other …
Brain ischemia: CT and MRI techniques in acute ischemic stroke
… The current available AIS treatments include intravenous thrombolysis with tissue
plasminogen activator during the first 4.5 h after clinical onset and intra-arterial (endovascular) …
plasminogen activator during the first 4.5 h after clinical onset and intra-arterial (endovascular) …
Acute stroke imaging research roadmap II
Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology
sponsored a series of working group meetings> 12 months, with the final meeting occurring …
sponsored a series of working group meetings> 12 months, with the final meeting occurring …
Neural network-based face detection
… Although the system was trained only on real faces, hand drawn faces are detected in H
and N. A, D, I, J, and K were scanned from photographs; B, H, and L were obtained from the …
and N. A, D, I, J, and K were scanned from photographs; B, H, and L were obtained from the …
Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial
A Furlan, R Higashida, L Wechsler, M Gent, H Rowley… - Jama, 1999 - jamanetwork.com
… infused at 60 mL/h. Otherwise, antithrombotic agents were prohibited for the first 24 hours. …
Recombinant prourokinase was infused at a rate of 30 mL/h. After 1 hour of r-proUK infusion (…
Recombinant prourokinase was infused at a rate of 30 mL/h. After 1 hour of r-proUK infusion (…
PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke
…, RT Higashida, AJ Furlan, MS Pessin, HA Rowley… - Stroke, 1998 - Am Heart Assoc
… 60 mL/h. The first 16 patients received a 100-IU/kg bolus followed by a 1000 IU/h constant
infusion … was altered to a 2000 IU bolus and 500 IU/h infusion (“low heparin”) for the remaining …
infusion … was altered to a 2000 IU bolus and 500 IU/h infusion (“low heparin”) for the remaining …
Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion–diffusion weighted imaging or perfusion CT (DIAS-2): a prospective …
Background Previous studies have suggested that desmoteplase, a novel plasminogen
activator, has clinical benefit when given 3–9 h after the onset of the symptoms of stroke in …
activator, has clinical benefit when given 3–9 h after the onset of the symptoms of stroke in …
Rotation invariant neural network-based face detection
In this paper, we present a neural network-based face detection system. Unlike similar
systems which are limited to detecting upright, frontal faces, this system detects faces at any …
systems which are limited to detecting upright, frontal faces, this system detects faces at any …
[HTML][HTML] Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases …
Purpose Hippocampal neural stem-cell injury during whole-brain radiotherapy (WBRT) may
play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid …
play a role in memory decline. Intensity-modulated radiotherapy can be used to avoid …
A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy
JM Skripak, SD Nash, H Rowley, NH Brereton… - Journal of Allergy and …, 2008 - Elsevier
BACKGROUND: Orally administered, food-specific immunotherapy appears effective in
desensitizing and potentially permanently tolerizing allergic individuals. OBJECTIVE: We sought …
desensitizing and potentially permanently tolerizing allergic individuals. OBJECTIVE: We sought …